Improved glucose metabolism following blockade of angiotensin converting enzyme but not angiotensin AT 1 receptors

By Chow L.   De Gasparo M.   Levens N.  

European Journal of Pharmacology, Vol. 282, Iss. 1, 1995-08 ,pp. : 77-86

Elsevier

Access to resources Recommend Favorite

Renin-angiotensin System Blockade at the Level of the Angiotensin Converting Enzyme or the Angiotensin Type-1 Receptor: Similarities and Differences

By  

Current Topics in Medicinal Chemistry, Vol. 4, Iss. 4, 2004-01 ,pp. : 473-481

Bentham Science Publishers

Access to resources Recommend Favorite

Effects of angiotensin II and angiotensin-converting enzyme inhibitors on human myocardium

By Lenz O.   Schmid B.   Kilter H.   La Rosee K.   Flesch M.   Kuhn-Regnier F.   Sudkamp M.   Bohm M.  

European Journal of Pharmacology, Vol. 294, Iss. 1, 1995-01 ,pp. : 17-27

Elsevier

Access to resources Recommend Favorite

Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Antagonists in Experimental Myocarditis

By  

Current Pharmaceutical Design, Vol. 9, Iss. 9, 2003-04 ,pp. : 723-735

Bentham Science Publishers

Access to resources Recommend Favorite

Advances in Angiotensin Converting Enzyme Inhibitors (ACEIs) and Angiotensin Receptor Blockers (ARBs)

By  

Mini Reviews in Medicinal Chemistry, Vol. 3, Iss. 6, 2003-09 ,pp. : 621-631

Bentham Science Publishers

Access to resources Recommend Favorite